Back

Lymphoma and long term outcomes after percutaneous coronary intervention

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology and non-ischaemic coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Isabel Canby Reeves

Riga (Latvia)

6 More presentations in this session

Presentation thumbnail
Predictors of new cancer diagnosis following a NSTEMI event: insights from a national cancer registry
Doctor Y. Yarkoni (Tel Hashomer, IL)
Abstract Slides Video
Presentation thumbnail
Nutritional and Inflammatory Status are Associated with Obesity Paradox in Coronary Artery Disease Patients Without Cancer
Doctor Y. Shirahama (Kumamoto, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic value of advanced lung cancer inflammation index in predicting 1-year mortality post-PCI in STEMI patients
Doctor G. Trimarchi (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Short-term outcomes of impella support in japanese patients with cardiogenic shock due to non-ischemic cardiomyopathy
Doctor M. Nishiwaki (Kawaguchi, JP)
Abstract Slides Video
Presentation thumbnail
Fulminant Myocarditis: clinical profile, outcomes and comparison with myocardial infarction-related cardiogenic shock
Doctor E. Garcia Martin (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-oncology and non-ischaemic coronary syndromes

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of new cancer diagnosis following a NSTEMI event: insights from a national cancer registry
thumbnail
Congress Presentation
Impact of cancer history on non-ST-segment elevation myocardial infarction (NSTEMI) prognosis, a propensity-score matching (PSM) analysis
thumbnail
Congress Presentation
Risk of cardiovascular disease in Hodgkin lymphoma patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources